These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30250021)

  • 1. Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer.
    Xia X; Liao Y; Guo Z; Li Y; Jiang L; Zhang F; Huang C; Liu Y; Wang X; Liu N; Liu J; Huang H
    Oncogenesis; 2018 Sep; 7(9):75. PubMed ID: 30250021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy.
    Zhao C; Chen X; Zang D; Lan X; Liao S; Yang C; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; He Z; Wang X; Liu J
    Biochem Pharmacol; 2016 Sep; 116():22-38. PubMed ID: 27381943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERα is a target for butein-induced growth suppression in breast cancer.
    Huang C; Xia X; He J; Liu Y; Shao Z; Hu T; Yu C; Liu X; Xu Q; Liu B; Liu N; Liao Y; Huang H
    Am J Cancer Res; 2020; 10(11):3721-3736. PubMed ID: 33294263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting proteasomal deubiquitinases USP14 and UCHL5 with b-AP15 reduces 5-fluorouracil resistance in colorectal cancer cells.
    Ding W; Wang JX; Wu JZ; Liu AC; Jiang LL; Zhang HC; Meng Y; Liu BY; Peng GJ; Lou EZ; Mao Q; Zhou H; Tang DL; Chen X; Liu JB; Shi XP
    Acta Pharmacol Sin; 2023 Dec; 44(12):2537-2548. PubMed ID: 37528233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers.
    Cai J; Xia X; Liao Y; Liu N; Guo Z; Chen J; Yang L; Long H; Yang Q; Zhang X; Xiao L; Wang X; Huang H; Liu J
    Oncotarget; 2017 Sep; 8(38):63232-63246. PubMed ID: 28968984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells.
    Thaler S; Schmidt M; Roβwag S; Thiede G; Schad A; Sleeman JP
    Oncotarget; 2017 Sep; 8(42):72281-72301. PubMed ID: 29069787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation.
    Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Wang X; Shi X; Liu J
    Cell Death Dis; 2017 Jul; 8(7):e2913. PubMed ID: 28682311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
    Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
    Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition.
    Huang H; Liu N; Liao Y; Liu N; Cai J; Xia X; Guo Z; Li Y; Wen Q; Yin Q; Liu Y; Wu Q; Rajakumar D; Sheng X; Liu J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):79. PubMed ID: 28619062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-Aided Ligand Discovery for Estrogen Receptor Alpha.
    Bafna D; Ban F; Rennie PS; Singh K; Cherkasov A
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deubiquitylatinase inhibitor b-AP15 induces c-Myc-Noxa-mediated apoptosis in esophageal squamous cell carcinoma.
    Sha B; Chen X; Wu H; Li M; Shi J; Wang L; Liu X; Chen P; Hu T; Li P
    Apoptosis; 2019 Oct; 24(9-10):826-836. PubMed ID: 31342239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome deubiquitinases as novel targets for cancer therapy.
    D'Arcy P; Linder S
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1729-38. PubMed ID: 22819849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases.
    Zhao C; Chen X; Yang C; Zang D; Lan X; Liao S; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; Dou QP; Wang X; Liu J
    Oncotarget; 2017 Feb; 8(8):13942-13956. PubMed ID: 28086217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of syndecan-binding protein enhances the inhibitory effect of tamoxifen and increases cellular sensitivity to estrogen.
    Zhang J; Qian X; Liu F; Guo X; Gu F; Fu L
    Cancer Biol Med; 2018 Feb; 15(1):29-38. PubMed ID: 29545966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
    Sui M; Jiang D; Hinsch C; Fan W
    Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to degrade estrogen receptor α in primary and ESR1 mutant-expressing metastatic breast cancer.
    Busonero C; Leone S; Bartoloni S; Acconcia F
    Mol Cell Endocrinol; 2019 Jan; 480():107-121. PubMed ID: 30389467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15.
    Mofers A; Perego P; Selvaraju K; Gatti L; Gullbo J; Linder S; D'Arcy P
    PLoS One; 2019; 14(10):e0223807. PubMed ID: 31639138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.
    Chen X; Wu J; Yang Q; Zhang X; Zhang P; Liao S; He Z; Wang X; Zhao C; Liu J
    Biometals; 2018 Feb; 31(1):29-43. PubMed ID: 29098502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.